KUALA LUMPUR, April 30 (Bernama) -- Last-minute buying lifted Bursa Malaysia’s benchmark index, reversing earlier losses as higher oil prices boosted sentiment for energy- and chemical-related counters. Rakuten Trade Sdn Bhd vice-president of equity research Thong Pak Leng said regional markets remained under pressure following negative cues from Wall Street, compounded by surging oil prices, mixed earnings, and a cautious US Federal Reserve stance. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) increased 1.60 points, or 0.09 per cent, to 1,722.02 from Wednesday’s close of 1,720.42. The benchmark index opened marginally lower at 1,720.23 and moved between a low of 1,712.14 and a high of 1,722.03 throughout the day. Market breadth, however, was negative, with losers trouncing gainers 816 to 360. A total of 546 counters were unchanged, 950 were untraded, and 77 were suspended. Turnover declined to 2.91 billion un...
Malaysia’s IPO market just received a major catalyst.
Sunway Healthcare Holdings Bhd has begun bookbuilding for a RM2.86 billion (US$734 million) IPO, potentially the country’s largest listing since 2017.
The company plans to list on March 18 at RM1.45 per share, implying a RM16.7 billion valuation.
That would make it the second-largest listed healthcare provider in Malaysia after IHH Healthcare Bhd.
Deal Snapshot
Shares offered: 1.97 billion
IPO price: RM1.45
Market cap: RM16.7 billion
Proceeds use:
Hospital expansion
New hospital construction
Redemption of Islamic medium-term notes
Cornerstone investors include:
JPMorgan Asset Management
Eastspring Investments
RBC Global Asset Management
Parent company: Sunway Bhd
Existing listed carve-outs include Sunway Construction Group Bhd and Sunway Real Estate Investment Trust.
Money Master Take
This IPO matters for three reasons beyond the headline size.
1️⃣ A Healthcare Growth Platform, Not a Defensive Play
Sunway Healthcare operates:
5 private hospitals
Ambulatory and specialty centers
3 new hospitals under construction
Plans for up to 5 additional facilities
This is an expansion story tied to:
Aging demographics
Rising middle-class healthcare spending
Medical tourism recovery
Key Insight: This is capacity-driven growth, not yield-driven stability.
IPO Window Is Reopening in Malaysia
Malaysia’s IPO proceeds fell 14% last year.
A RM2.86 billion deal signals:
Institutional liquidity is available
Valuation appetite has improved
Kuala Lumpur is trying to reassert itself regionally
The listing also comes as the MSCI Malaysia Index gained only 6.8% over the past year, underperforming broader Asia.
This creates room for capital rotation.
Carve-Out Strategy Unlocking Value
Sunway has a clear track record of spinning off mature units:
Construction
REIT
Now healthcare
Carve-outs typically:
Unlock higher sector-specific multiples
Improve capital allocation transparency
Reduce conglomerate discount
If priced well, this could narrow valuation gaps between healthcare pure-plays and diversified holding companies.
What Investors Should Watch
Key evaluation points:
IPO valuation vs IHH Healthcare multiples
Hospital bed capacity growth timeline
Debt reduction impact post-note redemption
Institutional oversubscription levels
Healthcare is generally a defensive-growth hybrid sector — but expansion-heavy models depend on occupancy ramp-up speed.
Bottom Line
Malaysia’s largest IPO in years signals improving primary market confidence.
Sunway Healthcare is positioned as a multi-year capacity expansion story.
Execution on hospital ramp-ups will determine post-listing performance.
This is less about short-term listing pop…
and more about whether Malaysia can support a second large-cap healthcare champion.
Comments
Post a Comment